Remedee Labs
Private Company
Total funding raised: $1.8M
Overview
Remedee Labs is a commercial-stage medical device and digital health company pioneering a novel, non-pharmaceutical approach to chronic pain. Its flagship products, Novi Rem™ for osteoarthritis pain and Fibro Rem™ for fibromyalgia, combine a proprietary millimeter wave neuromodulation wristband that stimulates the body's endorphin release with a holistic digital care platform. The company has achieved significant regulatory milestones, including the first CE mark in Europe for a medical device to treat fibromyalgia, and is backed by clinical data demonstrating improvements in pain, sleep, fatigue, and quality of life. Currently, its solutions are available only in France.
Technology Platform
Non-invasive millimeter wave (MMW) neuromodulation technology designed to stimulate peripheral nerves to trigger endogenous endorphin release, integrated with a digital services platform for remote monitoring, personalized coaching, and multidisciplinary care support.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Remedee competes in the non-pharmacological chronic pain management space, which includes wearable neuromodulation devices (e.g., TENS units, vagus nerve stimulators), prescription digital therapeutics for pain (e.g., cognitive behavioral therapy apps), and other complementary therapies. Its key differentiator is the specific millimeter-wave technology for endorphin stimulation combined with a holistic care platform, setting it apart from simpler, single-modality competitors.